PURPOSE To review prognostic and therapeutic applications of angiogenesis research in
breast carcinoma. METHODS We reviewed the (1) biologic role of angiogenesis, particularly …

Several investigators, the SEER data, and the ECOG/Intergroup study have shown that
patients with small tumors (< 0.5 cm) have a recurrence rate of less than 2%, compared to 20 …

Using the technique of differential cDNA library screening, a cDNA clone was isolated from
an estrogen receptor (ER)-positive breast carcinoma cell line (MCF7) cDNA library based …

PURPOSE: To determine the predictive value of vascular endothelial growth factor (VEGF)
for relapse-free survival (RFS) and overall survival (OS) in primary node-positive breast …

A review and update of published studies on prognostic factors support the following
conclusions: The number of axillary lymph nodes involved with tumor remains the most …

BACKGROUND The c‐met protooncogene encodes the met protein, the receptor for scatter
factor/hepatocyte growth factor, a growth factor that modulates the motility and stable …

The incidence of breast cancer is increasing in all Western countries. Due both to a more
widespread public education and to early diagnosis by mammography screening programs …

Nuclear receptors (NRs) have historically been at the forefront of cancer research, where
they are known to act as critical regulators of disease. They also serve as biomarkers for …

OBJECTIVE: Receptors for estrogen (ER), progesterone (PR), or androgen (AR) are
predictive and prognostic markers of malignancy of multiple endocrine organs, including …

In this study, we analyzed vitamin D receptor (VDR) expression and survival in a breast
cancer patient cohort of 82 breast cancer patients. Immunohistochemical analysis was …